A5067710734- Pharmaceutical Practices and Patient Outcomes
- Health Systems, Economic Evaluations, Quality of Life
- Electronic Health Records Systems
- Pharmaceutical studies and practices
- Medication Adherence and Compliance
- Pharmaceutical Economics and Policy
- Patient Safety and Medication Errors
- Atrial Fibrillation Management and Outcomes
- Pharmacovigilance and Adverse Drug Reactions
- Health Sciences Research and Education
- Diabetes Treatment and Management
- Opioid Use Disorder Treatment
- Biomedical Text Mining and Ontologies
- Heart Failure Treatment and Management
- Statistical Methods in Clinical Trials
- Dementia and Cognitive Impairment Research
- Treatment of Major Depression
- Health Policy Implementation Science
- Diabetes Management and Research
- Emergency and Acute Care Studies
- Mobile Health and mHealth Applications
- Antiplatelet Therapy and Cardiovascular Diseases
- Intensive Care Unit Cognitive Disorders
- Pharmacy and Medical Practices
- Pelvic floor disorders treatments
University of Utah
2019-2025
University of Montana
2020-2024
University of Utah Health Care
2024
China Pharmaceutical University
2023
E Ink (South Korea)
2022
University of Colorado Anschutz Medical Campus
1998-2021
Malone University
2011-2021
University of Arizona
2011-2020
National Health Council
2017-2020
VA Eastern Colorado Health Care System
2019
Background: A variety of measures have been developed to calculate refill adherence from administrative data such as pharmacy claims databases. These focused on improving the accuracy or clarifying evaluation time frame. As a result, there are many used assess that may not be comparable accurate. Objective: To compare available measures. Methods: systematic literature review was conducted identify current recently calculating data. MEDLINE search (January 1990–March 2006) undertaken using...
Estimating the amount and cost of excess antibiotic use in ambulatory practice identifying conditions that account for most are necessary to guide intervention policy decisions. Data from 1998 National Ambulatory Medical Care Survey, a sample survey United States physician practices, was used estimate primary care office visits prescription rates acute respiratory infections. Weight-averaged costs were calculated with 1996 marketing data adjusted inflation. In 1998, an estimated 76 million...
To estimate the cost-effectiveness of stroke prevention in patients with nonvalvular atrial fibrillation by using novel oral anticoagulants apixaban 5 mg, dabigatran 150 and rivaroxaban 20 mg compared warfarin.A Markov decision-analysis model was constructed data from clinical trials to evaluate lifetime costs quality-adjusted life-years warfarin. The modeled population a hypothetical cohort 70-year-old fibrillation, increased risk for (CHADS2 ≥ 1), renal creatinine clearance 50 mL/min, no...
<h3>Importance</h3> Current approaches to identifying individuals at high risk for opioid overdose target many patients who are not truly risk. <h3>Objective</h3> To develop and validate a machine-learning algorithm predict among Medicare beneficiaries with least 1 prescription. <h3>Design, Setting, Participants</h3> A prognostic study was conducted between September 1, 2017, December 31, 2018. Participants (n = 560 057) included fee-for-service without cancer filled or more prescriptions...
Obesity has clinical and economic consequences. Few studies have compared health care resource utilization between age- sex-matched obese nonobese persons.We conducted a retrospective study in individuals matched by age, sex, medical clinic, selected exclusionary diagnoses. Data collected included hospitalizations, outpatient visits, professional claims, prescriptions over 1 year. Costs were assigned to resources based on market prices using publicly available costs. Comorbid conditions...
Background: This study compared prevalent health utilization and costs for persons with without metabolic syndrome investigated the independent associations of various factors that make up syndrome. Methods: Subjects were enrollees three plans who had all clinical measurements (blood pressure, fasting plasma glucose, body mass index, triglycerides, high-density lipoprotein cholesterol) necessary to determine risk over 2-year period (n = 170,648). We used values, International Classification...
Pharmacy clinical decision-support (CDS) software that contains drug-drug interaction (DDI) information may augment pharmacists' ability to detect clinically significant interactions. However, studies indicate these systems miss some important The purpose of this study was assess the performance pharmacy CDS programs DDIs.Researchers made on-site visits 64 participating Arizona pharmacies between December 2008 and November 2009 analyze associated DDIs. Software evaluation conducted determine...
Background: Spinal muscular atrophy type 1 (SMA1) is a devastating genetic disease for which gene-replacement therapy may bring substantial survival and quality of life benefits.Objective: This study investigated the cost-effectiveness onasemnogene abeparvovec (AVXS-101) SMA1.Study design: A Markov model was used to estimate incremental ratio (ICER), expressed as cost/quality-adjusted year ($/QALY), AVXS-101 versus nusinersen over lifetime. Survival, healthcare costs QALYs were estimated...
The objectives of this study were to determine the relationship between drug therapy compliance and risk hospitalization economic outcomes, identify potential indicators compliance. We used computerized prescription records from 1054 patients at high for drug‐related problems. calculated a ratio 12‐month period correlated it with health care use, demographic variables, scores health‐related quality life. Univariate results suggested that increased age (p=0.05), number chronic conditions...
We examined the impact of ambulatory care clinical pharmacist interventions on and economic outcomes 208 patients with dyslipidemia 229 controls treated at nine Veterans Affairs medical centers. This was a randomized, controlled trial involving high risk drug‐related problems. Only those are reported here. In addition to usual care, pharmacists were responsible for providing pharmaceutical in intervention group. The control group did not receive care. Seventy‐two percent 70% required...
Background: Drug-drug interactions (DDIs) are preventable medical errors, yet exposure to DDIs continues despite systems that designed prevent such exposures. The purpose of this study was examine pharmacy characteristics may be associated with dispensed potential DDIs. Methods: This combined survey data from community pharmacies in 18 metropolitan statistical areas claims submitted 4 benefit managers (PBMs) over a 3-month period January 1, 2003 March 31, 2003. Pharmacy interest included...
The prevalence of 25 clinically important potential drug-drug interactions (DDIs) in a population represented by the drug claims database pharmacy benefit management company (PBM) was studied.A retrospective cross-sectional analysis pharmaceutical for almost 46 million participants PBM conducted to determine frequency DDIs previously identified as important. A DDI counted when drugs potentially interacting combinations were dispensed within 30 days each other during 25-month period between...